Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hiltunen

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Hypertension|September 1, 2007
Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertensionKimmo Porthan, Juha Virolainen, Timo P Hiltunen, et al.
Pharmacogenomics|March 30, 2017
Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responsesJenni M Rimpelä, Kimmo K Kontula, Frej Fyhrquist, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2000
Relationship of angiotensin-converting enzyme gene polymorphism to carotid wall thickness in middle-aged menX H Huang, A Loimaala, A Nenonen, et al.
American Journal of Hypertension|February 28, 2007
Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)Timo P Hiltunen, Timo Suonsyrjä, Tuula Hannila-Handelberg, et al.
Annals of Medicine|July 9, 2008
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive menKimmo Porthan, Matti Viitasalo, Timo P Hiltunen, et al.
Journal of Hypertension|May 14, 2008
Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES StudyTimo Suonsyrjä, Tuula Hannila-Handelberg, Kristian J Paavonen, et al.
BMC Medical Genetics|July 6, 2018
Genome-wide association study of nocturnal blood pressure dipping in hypertensive patientsJenni M Rimpelä, Ilkka H Pörsti, Antti Jula, et al.
BMC Medical Genetics|January 22, 2005
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertensionTuula Hannila-Handelberg, Kimmo Kontula, Ilkka Tikkanen, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Journal of the American Heart Association|August 20, 2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β<sub>1</sub>-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)Sonal Singh, Helen R Warren, Timo P Hiltunen, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Hypertension|September 1, 2007
Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertensionKimmo Porthan, Juha Virolainen, Timo P Hiltunen, et al.
Pharmacogenomics|March 30, 2017
Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responsesJenni M Rimpelä, Kimmo K Kontula, Frej Fyhrquist, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2000
Relationship of angiotensin-converting enzyme gene polymorphism to carotid wall thickness in middle-aged menX H Huang, A Loimaala, A Nenonen, et al.
American Journal of Hypertension|February 28, 2007
Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)Timo P Hiltunen, Timo Suonsyrjä, Tuula Hannila-Handelberg, et al.
Annals of Medicine|July 9, 2008
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive menKimmo Porthan, Matti Viitasalo, Timo P Hiltunen, et al.
Journal of Hypertension|May 14, 2008
Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES StudyTimo Suonsyrjä, Tuula Hannila-Handelberg, Kristian J Paavonen, et al.
BMC Medical Genetics|July 6, 2018
Genome-wide association study of nocturnal blood pressure dipping in hypertensive patientsJenni M Rimpelä, Ilkka H Pörsti, Antti Jula, et al.
BMC Medical Genetics|January 22, 2005
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertensionTuula Hannila-Handelberg, Kimmo Kontula, Ilkka Tikkanen, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Journal of the American Heart Association|August 20, 2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β<sub>1</sub>-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)Sonal Singh, Helen R Warren, Timo P Hiltunen, et al.
Pageof 6